Skip to main content

Table 2 Serum lipids and lipoproteins (mmol/l) during the study.

From: Short-term LDL cholesterol-lowering efficacy of plant stanol esters

  Experimental period Follow-up period   
  0 day 4 days 8 days 15 days 17 or 18 days 22 days P1 P2
Total cholesterol 6.33 ± 0.64 6.16 ± 0.74 5.81 ± 0.76a 6.06 ± 0.83 6.16 ± 0.75 6.30 ± 0.87 0.014 0.316
LDL cholesterol 4.51 ± 0.66 4.34 ± 0.69 4.06 ± 0.75a 4.04 ± 0.68a 4.21 ± 0.67 4.26 ± 0.72 0.001 0.183
HDL cholesterol 1.36 ± 0.31 1.34 ± 0.31 1.31 ± 0.30 1.36 ± 0.30 1.35 ± 0.34 1.37 ± 0.35 0.247 0.935
VLDL cholesterol 0.47 ± 0.26 0.48 ± 0.22 0.44 ± 0.27 0.67 ± 0.21a 0.60 ± 0.18 0.66 ± 0.54 0.011 0.811
Triglycerides 1.61 ± 0.54 1.41 ± 0.55 1.40 ± 0.57 1.61 ± 0.59 1.47 ± 0.46 1.90 ± 1.04 0.311 0.236
  1. Values are means ± SD, n = 11. 1 indicate the significance of the differences for overall changes during the experimental period (days 0–15) analyzed with analysis of variance for repeated measurements (MANOVA). 2 indicate the significance of the differences for overall changes during the follow-up period (days 15–22) analyzed with analysis of variance for repeated measurements (MANOVA). a p < 0.05 significantly different from the values of 0 day analyzed with paired t-test with Bonferroni correction.
  2. Footnotes. During the experimental period the percentage changes (versus 0 day) in serum total cholesterol were -2.6 ± 8.1%, -8.2 ± 8.7% and -4.3 ± 8.1% at days 4, 8 and 15, respectively, and during the follow up period the changes were -2.7 ± 7.2% and -0.6 ± 8.8% at days 17/18 and 22, respectively. Respective changes in serum LDL cholesterol were -3.5 ± 8.9%, -9.9 ± 10.4%, -10.2 ± 10.5%, -6.5 ± 8.7% and -5.3 ± 10.0%.